Product NDC: | 62032-411 |
Proprietary Name: | REFISSA |
Non Proprietary Name: | TRETINOIN |
Active Ingredient(s): | .5 mg/g & nbsp; TRETINOIN |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 62032-411 |
Labeler Name: | Obagi Medical Products, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076498 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100222 |
Package NDC: | 62032-411-20 |
Package Description: | 20 g in 1 TUBE (62032-411-20) |
NDC Code | 62032-411-20 |
Proprietary Name | REFISSA |
Package Description | 20 g in 1 TUBE (62032-411-20) |
Product NDC | 62032-411 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | TRETINOIN |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20100222 |
Marketing Category Name | ANDA |
Labeler Name | Obagi Medical Products, Inc. |
Substance Name | TRETINOIN |
Strength Number | .5 |
Strength Unit | mg/g |
Pharmaceutical Classes | Retinoid [EPC],Retinoids [Chemical/Ingredient] |